Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias

International Journal of Hematology

Volumn 80, Issue 1, 2004, Pages 52-58

  Sugahara, Kazuyuki ^a   Uemura, Akiko ^a   Harasawa, Hitomi ^a   Nagai, Hiroshi ^a   Hirakata, Yoichi ^a   Tomonaga, Masao ^a   Murata, Kenn ^a   Sohda, Hiroshi ^a   Nakagoe, Toru ^a   Shibasaki, Sin Ichi ^a   Yamada, Yasuaki ^a   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

ATL; Biomarker; HTLV 1; Real time PCR; Survivin

Indexed keywords

BIOLOGICAL MARKER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; SURVIVIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DISEASE MARKER; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; T CELL LEUKEMIA; UPREGULATION;

ACUTE DISEASE; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 3142690454     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04031     Document Type: Article

References (25)

1. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3:46-54.
2. Temme A, Rieger M, Reber F, et al. Localization, dynamics, and function of survivin revealed by expression of functional survivin-DsRed fusion proteins in the living cell. Mol Biol Cell. 2003;14: 78-92.
3. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3: 917-921.
4. Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood. 2001;97: 2784-2790.
5. Schmidt SM, Schag K, Muller MR, et al. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells. Blood. 2003;102: 571-576.
6. Mesri M, Wall RW, Li J, Kim RW, Altieri DC. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest. 2001;108:981-990.
7. Kamihira S, Yamada Y, Hirakata Y, et al. Aberrant expression of caspase cascade regulatory genes in ATL: survivin is an important determinant for prognosis. Br J Haematol. 2001;114:63-69.
8. Nakayama K, Kamihira S. Survivin an important determinant for prognosis in ATL: a novel biomarker in practical hemato-oncology. Leuk Lymphoma. 2002;43:2249-2255.
9. Paydas S. Tanriverdi K. Yavuz S, Disel U, Sahin B, Burgut R. Survivin and aven: two distinct antiapototic signals in acute leukemias. Ann Oncol. 2003;14:1045-1050.
10. Miyachi K, Sasaki K, Onodera S, et al. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer. 2003;6:217-224.
11. Hayashibara T, Yamada Y, Nakayama S, et al. Resveratol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for ATL chemotherapy. Nutr Cancer. 2002;44:192-201.
12. Mori N, Yamada Y, Hatta T, et al. Expression of survivin in HTLV-1-infected T-cell lines and primary ATL cells. Biochem Biophys Res Commun. 2001;282:1110-1113.
13. Sugahara K, Yamada Y, Hiragata Y, et al. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines. Int J Cancer. 1997;72:128-132.
14. Yamada Y, Ohmoto Y, Yamamura M, et al. Plasma M-CSF as an indicator of response to chemotherapy in adult T cell leukemia patients. Leuk Lymphoma. 1996;22:457-461.
15. Kamihira S, Dateki N, Sugahara K, et al. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol. 2003; 25:111-117.
16. Badran A, Yoshida A, Wano Y, et al. Expression of the antiapoptotic gene survivin in chronic myeloid leukemia. Anticancer Res. 2003;23:589-592.
17. Mori A, Wada H, Nishimura Y, Okamoto T, Takemoto Y, Kakishita E. Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol. 2002;75:161-165.
18. Munzert G, Kirchner D, Stobbe H, et al. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-κB/Rel-regulated inhibitors of apoptosis. Blood. 2002;100:3749-3756.
19. Granziero L, Ghia P, Circosta P, et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood. 2001;97: 2777-2783.
20. Nakagawa Y, Yamaguchi S, Hasegawa M, et al. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia. Leuk Res. 2004;28:487-494.
21. Ullmannova V, Haskovec C. The use of housekeeping genes (HKG) as an internal control for the detection of gene expression by quantitative real-time RT-PCR. Folia Biol (Praha). 2003;49: 211-216.
22. Aerts JL, Gonzales MI, Topalian SL. Selection of appropriate control genes to assess expression of tumor antigens using real-time PCR. Biotechniques. 2004;36:84-86.
23. + acute myeloid leukemia based on quantification of fusion transcripts. Blood. 2003;102:2746-2755.
24. Watanabe T. HTLV-1 associated diseases. Int J Hematol. 1997;66: 257-278.
25. Yasunaga J. Matsuoka M. Leukemogenesis of adult T-cell leukemia. Int J Hematol. 2003;78:312-320.